SCHEMBL4153459

SCHEMBL4153459

O=C1N[C@H]2[C@H](CS[C@H]2CCCC(C(=O)O)N2C(=O)CC(S(=O)(=O)O)C2=O)N1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.48
MEN1 O00255 1/20 0.48
ABL1 P00519 1/20 0.48
LMNA P02545 1/20 0.48
PKM P14618 1/20 0.48
IDE P14735 1/20 0.48
MAPK1 P28482 1/20 0.48
KMT2A Q03164 1/20 0.48
RIN1 Q13671 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
HLCS P50747 6/20 0.45
CA12 O43570 6/20 0.40
CA1 P00915 6/20 0.40
CA2 P00918 6/20 0.40
CA9 Q16790 6/20 0.40
PTPRF P10586 2/20 0.39
PTPN2 P17706 2/20 0.39
PTPN1 P18031 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23124403 0.82 TDP1 (0.57) TDP1MEN1ABL1LMNAPKM
SCHEMBL625200 0.82 TDP1 (0.57) TDP1MEN1ABL1LMNAPKM
SCHEMBL5075016 0.80 TDP1 (0.47) TDP1MEN1ABL1LMNAPKM
SCHEMBL2232070 0.79 TDP1 (0.56) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL1023525 0.78 TDP1 (0.67) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL1270216 0.78 TDP1 (0.67) TDP1MEN1ABL1LMNAPKM
Biotin SCHEMBL29531755 0.77 TDP1 (0.69) TDP1MEN1ABL1LMNAPKM
SCHEMBL29613855 0.77 TDP1 (0.57) TDP1MEN1ABL1LMNAPKM
SCHEMBL6847325 0.76 TDP1 (0.60) TDP1MEN1ABL1LMNAPKM
SCHEMBL1080634 0.76 TDP1 (0.47) TDP1MEN1ABL1LMNAPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3040417-B1 MACROCYCLIC PEPTIDE, METHOD FOR PRODUCING SAME, AND SCREENING METHOD USING MACROCYCLIC PEPTIDE LIBRARY UNIV TOKYO (JP) 2023-12-13 EP disclosed
US-10234460-B2 Macrocyclic peptide, method for producing same, and screening method using macrocyclic peptide library THE UNIVERSITY OF TOKYO (JP) 2019-03-19 US disclosed
US-20160209421-A1 Macrocyclic Peptide, Method for Producing Same, and Screening Method Using Macrocyclic Peptide Library THE UNIVERSITY OF TOKYO (JP) 2016-07-21 US disclosed
EP-3040417-A1 MACROCYCLIC PEPTIDE, METHOD FOR PRODUCING SAME, AND SCREENING METHOD USING MACROCYCLIC PEPTIDE LIBRARY The University of Tokyo (JP) 2016-07-06 EP disclosed
US-20090039316-A1 DOPED-TYPE METAL SULFIDE PHOSPHOR NANOPARTICLE, DISPERSION THEREOF, AND METHOD FOR PRODUCING THE SAME FUJIFILM CORPORATION (JP) 2009-02-12 US disclosed
US-7462300-B2 Surface modified with surface modifier such as mercaptoacetic acid, 2-mercaptoethylamine; applicable, for example, to a fluorescently-labeling material and a luminescent device FUJIFILM CORPORATION (JP) 2008-12-09 US disclosed
US-7462299-B2 Doped-type metal sulfide phosphor nanoparticle, dispersion thereof, and method for producing the same FUJIFILM CORPORATION (JP) 2008-12-09 US disclosed
US-7338618-B2 Doped-type metal sulfide phosphor nanoparticle, dispersion thereof, and method for producing the same FUJIFILM CORPORATION (JP) 2008-03-04 US disclosed
US-20070125985-A1 Doped-type metal sulfide phosphor nanoparticle, dispersion thereof, and method for producing the same FUJI PHOTO FILM CO., LTD. 2007-06-07 US disclosed
US-20070108415-A1 Doped-type metal sulfide phosphor nanoparticle, dispersion thereof, and method for producing the same FUJI PHOTO FILM CO., LTD.. 2007-05-17 US disclosed
US-20050121648-A1 Doped-type metal sulfide phosphor nanoparticle, dispersion thereof, and method for producing the same FUJI PHOTO FILM CO., LTD. (JP) 2005-06-09 US disclosed
US-20050106570-A1 Adsorption of impurities is inhibited; semiconductors, for genetic replication; competitive binding JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2005-05-19 US disclosed
EP-1496363-A1 BIOCHIP SENSOR SURFACE CARRYING POLYETHYLENE GLYCOLATED NANOPARTICLES Japan Science and Technology Agency (JP) 2005-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10234460-B2 Macrocyclic peptide, method for producing same, and screening method using macrocyclic peptide library VIP, SLC7A1, PITRM1 TDP1 4780/4885MEN1 429/4885ABL1 4142/4885
US-20160209421-A1 Macrocyclic Peptide, Method for Producing Same, and Screening Method Using Macrocyclic Peptide Library VIP, SLC7A1, PITRM1 TDP1 4780/4885MEN1 429/4885ABL1 4142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.